Loading clinical trials...
Loading clinical trials...
This study aims to investigate acceptability and feasibility of a new version of the Imaginator intervention, Imaginator 2.0, targeting self-harm behaviour in young people aged 12-25 under mental heal...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Imperial College London
Collaborators
NCT04946253 · Child Behavior Problem, Attention Deficit and Disruptive Behavior Disorders
NCT06535100 · Child Behavior Problem
NCT04763720 · Psychiatric Problem, Child Neglect, and more
NCT03910491 · Child Behavior Problem, Child Behavior Disorders, and more
NCT05444205 · Child Development, Child Language, and more
West London NHS Trust
London
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions